These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14581268)

  • 41. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.
    Fisher BJ; Perera FE; Cooke AL; Opeitum A; Venkatesan V; Dar AR; Stitt L
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):541-50. PubMed ID: 9231678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.
    Whelan TJ; Lada BM; Laukkanen E; Perera FE; Shelley WE; Levine MN
    Cancer Prev Control; 1997 Aug; 1(3):228-40. PubMed ID: 9765748
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pooled long-term outcomes from two randomized trials of axillary node sampling with axillary radiotherapy versus axillary node clearance in patients with operable node-positive breast cancer.
    Bing AU; Kerr GR; Jack W; Chetty U; Williams LJ; Rodger A; Dixon JM
    Br J Surg; 2016 Jan; 103(1):81-7. PubMed ID: 26768099
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Results of a breast-cancer-surgery trial compared with observational data from routine practice.
    Marubini E; Mariani L; Salvadori B; Veronesi U; Saccozzi R; Merson M; Zucali R; Rilke F
    Lancet; 1996 Apr; 347(9007):1000-3. PubMed ID: 8606561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
    Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
    Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.
    Bartelink H; Horiot JC; Poortmans P; Struikmans H; Van den Bogaert W; Barillot I; Fourquet A; Borger J; Jager J; Hoogenraad W; Collette L; Pierart M;
    N Engl J Med; 2001 Nov; 345(19):1378-87. PubMed ID: 11794170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
    Galimberti V; Cole BF; Viale G; Veronesi P; Vicini E; Intra M; Mazzarol G; Massarut S; Zgajnar J; Taffurelli M; Littlejohn D; Knauer M; Tondini C; Di Leo A; Colleoni M; Regan MM; Coates AS; Gelber RD; Goldhirsch A;
    Lancet Oncol; 2018 Oct; 19(10):1385-1393. PubMed ID: 30196031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer.
    Jacobson JA; Danforth DN; Cowan KH; d'Angelo T; Steinberg SM; Pierce L; Lippman ME; Lichter AS; Glatstein E; Okunieff P
    N Engl J Med; 1995 Apr; 332(14):907-11. PubMed ID: 7877647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.
    Wang J; Wang S; Tang Y; Jing H; Sun G; Jin J; Liu Y; Song Y; Wang W; Fang H; Ren H; Yu Z; Li Y
    Clin Breast Cancer; 2018 Oct; 18(5):e975-e984. PubMed ID: 30054238
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis.
    Willner J; Kiricuta IC; Kölbl O
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):853-63. PubMed ID: 9128962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer.
    Sarrazin D; Lê MG; Arriagada R; Contesso G; Fontaine F; Spielmann M; Rochard F; Le Chevalier T; Lacour J
    Radiother Oncol; 1989 Mar; 14(3):177-84. PubMed ID: 2652199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term outcomes among breast cancer patients with extensive regional lymph node involvement: implications for locoregional management.
    Braunstein LZ; Galland-Girodet S; Goldberg S; Warren LE; Sadek BT; Shenouda MN; Abi-Raad RF; MacDonald SM; Taghian AG
    Breast Cancer Res Treat; 2015 Dec; 154(3):633-9. PubMed ID: 26585579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breast-conserving surgery in breast cancer.
    Tenea Cojan TS; Vidrighin CD; Ciobanu M; Paun I; Teodorescu M; Mogos G; Tenovici M; Florescu M; Mogos D
    Chirurgia (Bucur); 2012; 107(5):616-25. PubMed ID: 23116836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognosis for breast cancer surgery and radiation therapy compared with mastectomy alone. A retrospective analysis of 759 patients with stage I/II breast cancer.
    Janjan NA; Murray KJ; Conway P; Walker A; Wilson JF
    Cancer; 1992 Jun; 69(11):2842-8. PubMed ID: 1571915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer.
    Danforth DN; Zujewski J; O'Shaughnessy J; Riseberg D; Steinberg SM; McAtee N; Noone M; Chow C; Chaudhry U; Lippman M; Jacobson J; Okunieff P; Cowan KH
    Ann Surg Oncol; 1998 Mar; 5(2):150-8. PubMed ID: 9527268
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Results of wide excision for mammary recurrence after breast-conserving therapy.
    Kurtz JM; Amalric R; Brandone H; Ayme Y; Spitalier JM
    Cancer; 1988 May; 61(10):1969-72. PubMed ID: 3129175
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microscopic residual disease is a risk factor in the primary treatment of breast cancer.
    Schuck A; Könemann S; Heinen K; Rübe CE; Hesselmann S; Reinartz G; Schüller P; Micke O; Schäfer U; Willich N
    Strahlenther Onkol; 2002 Jun; 178(6):307-13. PubMed ID: 12122786
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
    Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK
    Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.